vTv Therapeutics (VTVT) Operating Margin Growth (5y) (2019 - 2026)

vTv Therapeutics (VTVT) Operating Margin Growth (5y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 vTv Therapeutics 19.21 Mn 19.21 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 49,679.00
Dec 31, 2024 6.25 Mn
Mar 31, 2024 -9,723.00
Dec 31, 2022 -6.50 Mn
Jun 30, 2022 5.23 Mn
Mar 31, 2022 4.55 Mn
Dec 31, 2021 -8.84 Mn
Sep 30, 2021 3.55 Mn
Jun 30, 2021 -4.38 Mn
Mar 31, 2021 316,743.00
Dec 31, 2020 493,568.00
Sep 30, 2020 -3.34 Mn
Mar 31, 2020 -6.36 Mn
Dec 31, 2019 -9.05 Mn
Sep 30, 2019 -6.64 Mn